Ancora Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.84M Hold
9,141
0.04% 295
2025
Q4
$1.89M Hold
9,141
0.04% 308
2025
Q3
$1.64M Sell
9,141
-615
-6% -$105K 0.03% 331
2025
Q2
$1.57M Sell
9,756
-23
-0.2% -$3.66K 0.03% 329
2025
Q1
$1.66M Buy
+9,779
New +$1.7M 0.04% 306
2024
Q4
Sell
-10,677
Closed -$1.84M 1833
2024
Q3
$1.84M Sell
10,677
-570
-5% -$94.4K 0.04% 290
2024
Q2
$1.73M Sell
11,247
-208
-2% -$31.2K 0.04% 291
2024
Q1
$1.76M Sell
11,455
-133
-1% -$20.3K 0.04% 294
2023
Q4
$1.83M Sell
11,588
-1,828
-14% -$263K 0.04% 278
2023
Q3
$1.96M Sell
13,416
-1,327
-9% -$202K 0.05% 253
2023
Q2
$2.26M Sell
14,743
-35
-0.2% -$5.46K 0.06% 235
2023
Q1
$2.29M Sell
14,778
-10
-0.1% -$1.57K 0.07% 225
2022
Q4
$2.28M Sell
14,788
-392
-3% -$57.8K 0.07% 236
2022
Q3
$2M Sell
15,180
-700
-4% -$98.2K 0.06% 240
2022
Q2
$2.15M Sell
15,880
-3,027
-16% -$417K 0.06% 244
2022
Q1
$2.82M Sell
18,907
-1,860
-9% -$275K 0.07% 227
2021
Q4
$3.36M Sell
20,767
-364
-2% -$58.9K 0.08% 211
2021
Q3
$3.51M Buy
+21,131
New +$3.61M 0.09% 204
2021
Q2
Sell
-21,608
Closed -$3.47M 1950
2021
Q1
$3.47M Sell
21,608
-1,011
-4% -$173K 0.1% 199
2020
Q4
$3.8M Buy
+22,619
New +$3.67M 0.12% 175
2020
Q1
Sell
-24,797
Closed -$3.69M 1442
2019
Q4
$3.69M Buy
24,797
+344
+1% +$47.2K 0.14% 172
2019
Q3
$3.03M Buy
+24,453
New +$3.26M 0.13% 180
2018
Q4
Sell
-22,168
Closed -$3.51M 800
2018
Q3
$3.51M Buy
22,168
+208
+0.9% +$31.5K 0.14% 190
2018
Q2
$3.08M Sell
21,960
-165
-0.7% -$22.7K 0.13% 191
2018
Q1
$2.94M Sell
22,125
-116
-0.5% -$15.8K 0.13% 190
2017
Q4
$2.77M Sell
22,241
-37
-0.2% -$4.57K 0.15% 180
2017
Q3
$2.76M Buy
22,278
+100
+0.5% +$11.8K 0.16% 173
2017
Q2
$2.53M Buy
22,178
+109
+0.5% +$11.7K 0.16% 173
2017
Q1
$2.32M Sell
22,069
-195
-0.9% -$19.5K 0.16% 182
2016
Q4
$2.02M Buy
22,264
+1,005
+5% +$94.1K 0.15% 184
2016
Q3
$2.12M Sell
21,259
-960
-4% -$94.2K 0.21% 130
2016
Q2
$1.99M Sell
22,219
-883
-4% -$81.1K 0.23% 123
2016
Q1
$2.02M Buy
23,102
+535
+2% +$47.1K 0.25% 110
2015
Q4
$2.55M Sell
22,567
-445
-2% -$47.9K 0.33% 86
2015
Q3
$2.33M Sell
23,012
-1,629
-7% -$194K 0.3% 88
2015
Q2
$3.06M Buy
+24,641
New +$2.97M 0.36% 77
2015
Q1
Sell
-25,583
Closed -$2.89M 72
2014
Q4
$2.61M Sell
25,583
-250
-1% -$24.4K 0.32% 81
2014
Q3
$2.37M Sell
25,833
-719
-3% -$62.4K 0.3% 97
2014
Q2
$2.19M Sell
26,552
-1,757
-6% -$134K 0.28% 97
2014
Q1
$2.17M Sell
28,309
-11,324
-29% -$883K 0.31% 91
2013
Q4
$2.74M Sell
39,633
-1,452
-4% -$95.3K 0.41% 68
2013
Q3
$2.66M Buy
41,085
+3,748
+10% +$237K 0.46% 56
2013
Q2
$2.17M Buy
+37,337
New +$2.13M 0.37% 67

Other funds holding FBT

Ancora Advisors's FBT Position: Q1 2026 in Review

Ancora Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 9,141 shares worth $1.84M. The position accounts for 0.04% of the portfolio, ranked #295.

Ancora Advisors first reported a position in FBT in Q2 2013 and has held it in 43 quarters since. The position peaked at $3.8M in Q4 2020. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Ancora Advisors held 9,141 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.84M as of Q1 2026.
  • Ancora Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of Ancora Advisors's portfolio in Q1 2026, its #295 holding.
  • Ancora Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 43 quarters since.
  • Ancora Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.8M in Q4 2020.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.